Metropolitan Life Insurance Co. NY lowered its stake in shares of Maximus Inc. (NYSE:MMS) by 63.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,933 shares of the health services provider’s stock after selling 64,776 shares during the period. Metropolitan Life Insurance Co. NY owned approximately 0.06% of Maximus worth $2,644,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently modified their holdings of the company. Amundi Pioneer Asset Management Inc. bought a new position in Maximus during the fourth quarter worth about $163,000. Steward Partners Investment Advisory LLC bought a new position in Maximus during the fourth quarter worth about $169,000. Capital One National Association bought a new position in Maximus during the fourth quarter worth about $213,000. Zeke Capital Advisors LLC bought a new position in Maximus during the fourth quarter worth about $222,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Maximus by 51.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,581 shares of the health services provider’s stock worth $256,000 after buying an additional 1,214 shares during the last quarter. Hedge funds and other institutional investors own 96.71% of the company’s stock.
In related news, General Counsel David Francis sold 3,600 shares of Maximus stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $64.50, for a total value of $232,200.00. Following the sale, the general counsel now owns 10,017 shares of the company’s stock, valued at approximately $646,096.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Russell A. Beliveau sold 1,000 shares of Maximus stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $71.73, for a total value of $71,730.00. The disclosure for this sale can be found here. Insiders have sold a total of 44,600 shares of company stock worth $3,014,830 in the last quarter. 3.10% of the stock is currently owned by company insiders.
MMS has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded Maximus from a “sell” rating to a “hold” rating in a report on Wednesday, January 17th. Canaccord Genuity reduced their target price on Maximus from $71.00 to $65.00 and set a “hold” rating on the stock in a report on Friday, February 9th. Finally, Maxim Group restated a “hold” rating and set a $69.00 target price (up previously from $66.00) on shares of Maximus in a report on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $66.60.
Maximus Inc. (MMS) opened at $65.96 on Friday. Maximus Inc. has a 1-year low of $57.12 and a 1-year high of $72.71. The company has a current ratio of 2.57, a quick ratio of 2.57 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $4,387.58, a PE ratio of 21.15, a PEG ratio of 2.24 and a beta of 1.18.
Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, February 8th. The health services provider reported $0.78 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.77 by $0.01. Maximus had a return on equity of 22.93% and a net margin of 8.99%. The business had revenue of $623.10 million for the quarter, compared to analysts’ expectations of $624.36 million. During the same quarter in the previous year, the business posted $0.71 EPS. Maximus’s revenue for the quarter was up 2.6% on a year-over-year basis. analysts forecast that Maximus Inc. will post 3.44 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th were issued a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend was Wednesday, February 14th. Maximus’s dividend payout ratio (DPR) is presently 5.36%.
COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/03/23/maximus-inc-mms-holdings-cut-by-metropolitan-life-insurance-co-ny.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.